Release Date: 28/04/21 17:48 Summary: Appendix 4C - quarterly Price Sensitive: Yes Download Document 482.45KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%